What's new

EMEA-003196-PIP01-22-M01

EMEA-003196-PIP01-22-M01

Jun 24, 2025 - 17:50
 0
EMEA-003196-PIP01-22-M01
EMEA-003196-PIP01-22-M01
Read More

Tags:

Previous Article

Opinion/decision on a Paediatric investigation plan (PIP): Uplizna, Inebilizumab...

Next Article

Opinion/decision on a Paediatric investigation plan (PIP): Vanflyta, Quizartinib...

Related Posts

Human medicines European public assessment report (EPAR): Arexvy, recombinant respiratory syncytial virus pre-fusion F protein, adjuvanted with AS01E, Date of authorisation: 06/06/2023, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

May 27, 2025  0

EMEA-003333-PIP01-22

EMEA-003333-PIP01-22

Jun 10, 2025  0

List of centrally authorised products with safety-relat...

May 27, 2025  0